News

Medtronic, Inc. (NYSE: MDT) today announced the first patient implant for the REVEAL AF (Incidence of AF in High Risk Patients) Clinical Trial, which through continuous cardiac monitoring will evaluate the incidence of atrial fibrillation...

Today at the Boston Atrial Fibrillation (AF) Symposium 2013, Philips Healthcare is introducing its latest innovations in advanced imaging integration for electrophysiologists, showcasing its new EP navigator offering - a novel approach to 3D...

Second-Generation Sheath May Facilitate Easier Access to the Inferior Veins When Treating Paroxysmal Atrial Fibrillation Medtronic, Inc. announced Food and Drug Administration (FDA) clearance and U.S. launch of the FlexCath Advance™...

Investigation to Evaluate Safety and Effectiveness of New ProMRI® Pacing System BIOTRONIK, a leading manufacturer of high-quality implantable cardiac devices and a pioneer of wireless remote monitoring technologies, announced that the U.S....

Fully automatic AEDs advanced arrhythmia detection technology gives virtually anyone the ability to save a life Designed to provide a shock automatically when a heart arrhythmia is detected, the Defibtech Lifeline™ AUTO fully automatic...

THE HEART HOSPITAL Baylor Plano is pleased to announce the official opening of its second comprehensive outpatient facility – the Center for Advanced Cardiovascular Care (CACC) at McKinney. To mark the occasion, the hospital will host two...

Decision on Trinity Health marks milestone for program The Joint Commission and The American Heart/American Stroke Association announced Trinity Health in Minot, North Dakota, is the 1,000th Certified Primary Stroke Center in the U.S. The...

CardioFocus, Inc., developer of the HeartLight® Endoscopic Ablation System for the treatment of atrial fibrillation (AF), announces the U.S. pivotal trial evaluating the safety and efficacy of the HeartLight system is approximately half...

Medtronic-Sponsored Study Aims to Support Worldwide Indication Expansion for CRT-P in a Significantly Underserved Heart Failure Patient Population Medtronic, Inc. announced the first patient enrollment in MIRACLE EF, a global clinical trial...